Share this article
SACRAMENTO, Calif., April 20, 2021 /PRNewswire/
Community Psychiatry, a leading independent provider of outpatient behavioral health services, today announced it has expanded its board of directors with the appointment of Scott L. Rauch, M.D. Dr. Rauch will oversee Community Psychiatry s investment in expanding access to mental health services across delivery channels, drive improved outcomes and clinical pathways, track quality data and increase opportunities for mental health clinicians to integrate with primary care providers. We are honored to welcome Dr. Rauch to our Board of Directors, said Chris Brengard, Chief Executive Officer of Community Psychiatry. Dr. Rauch joins Community Psychiatry at a pivotal time as we continue to expand our team of clinicians who are committed to improving clinical outcomes through evidence-based care.
NA Proactive news snapshot: Lexaria Bioscience Corp, New Pacific Metals Corp, HempFusion Wellness Inc, Gevo Inc, Information Services Corporation, Century Global Commodities Corporation, CleanSpark Inc, Alpine 4 Holdings Inc, Karora Resources Inc UPDATE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Lexaria Bioscience Corp, New Pacific Metals Corp, HempFusion Wellness Inc, Gevo Inc, Information Services Corporation, Century Global Commodities Corporation, CleanSpark Inc, Alpine 4 Holdings Inc, Karora Resources Inc UPDATE
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: HealthLynked Corp, The Valens Company Inc, Electric Royalties Ltd, Delta 9 Cannabis Inc …
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
E-Mail
Philadelphia, April 15, 2021 -A new study shows that markers of fear recall differ between men and women, but in a hormone-dependent manner.
Aberrant fear-memory processing in the brain is thought to underlie anxiety disorders, which affect hundreds of millions of people worldwide. The neurobiological mechanisms underlying these disorders remain poorly understood, but recent studies suggest that neural oscillations in the prefrontal cortex can reflect the strength of fear recall activity, providing a physiological measure.
Women suffer from anxiety disorders at twice the rate of men and indeed the literature shows that there are sex differences in fear recall behaviors, but this area of study has not been extended to neural oscillations. Additional studies suggest a modulatory role for the female sex hormone estradiol (E2) for fear recall and extinction recall.